Reistone Biopharma Company Limited (Reistone Biopharma) recently announced the appointment of Andrew Chen as Vice President, Head of Finance.

Shanghai, China/ Chicago, US/July 13, 2020/Reistone Biopharma Company Limited (Reistone Biopharma) recently announced the appointment of Dr. Qais Mekki as Senior Vice President, Head of International Development, US Site Head. He will be based in Chicago

Hengrui Medicine (600276) announced in the evening that Reistone Biopharma Company Limited, a subsidiary of the company, recently received the Notice of Clinical Trial approved and issued by NMPA.